DexCom, Inc. (DXCM), a leading medical device company based in San Diego, specializes in continuous glucose monitoring (CGM) systems. With a market capitalization of $32.5 billion, DexCom’s innovative technology includes a small, implantable sensor that tracks glucose levels beneath the skin and transmits real-time data to an external receiver.
The company is set to announce its fiscal 2025 second-quarter earnings after the market closes on Wednesday, July 30. Analysts are anticipating a profit of $0.45 per share on a diluted basis, reflecting a 4.7% increase from the year-ago quarter’s $0.43 per share. While DexCom has exceeded consensus estimates in two of the last four quarters, it has fallen short on two other occasions.
Looking ahead, analysts project that DXCM will report earnings per share (EPS) of $2.03 for the full year, marking a 23.8% increase from $1.64 in fiscal 2024. Furthermore, the company’s EPS is expected to rise by 24.6% year over year to $2.53 in fiscal 2026.
Over the past 52 weeks, DexCom’s shares have declined by 25.2%, underperforming the S&P 500’s 13.4% gains and the Health Care Select Sector SPDR Fund’s 5.4% dip during the same period. On July 1, the company’s shares experienced a more than 4% drop following the U.S. government’s proposed changes to payment schedules and the introduction of a competitive bidding program for diabetes devices, impacting the broader glucose monitoring and insulin pump sector.
Despite these challenges, analysts maintain a very positive outlook on DXCM stock, with an overall “Strong Buy” rating. Out of 25 analysts covering the stock, 20 recommend a “Strong Buy,” one suggests a “Moderate Buy,” and four advise a “Hold.” The average analyst price target for DXCM is $99.68, indicating a potential upside of 20.2% from the current levels.
In conclusion, DexCom continues to innovate in the field of continuous glucose monitoring, despite recent market fluctuations. Investors and analysts remain optimistic about the company’s future prospects, highlighting its strong performance and potential for growth in the coming years.
This article was originally published on Barchart.com and has been rewritten for a WordPress platform, incorporating key points and information from the original source.
